ConductScience.org, home

Trial · NCT03275350

Outcomes13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With HIV Viral Suppression, Missing Imputed as Unsuppressed12 weeks and 24 weeksNon-inferiority analyses of HIV viral suppression by treatment arm Intent to Treat Group Missing imputed as unsuppressedParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With HIV Viral Suppression, Complete Case12 weeks and 24 weeksNon-inferiority analyses of HIV viral suppression by treatment arm Complete case: Includes 81 participants with non-missing viral load data at 12 and 24 weeksParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With HIV Viral Suppression, Per-protocol12 weeks and 24 weeks
Non-inferiority analyses of HIV viral suppression by treatment arm Missing as unsuppressed Per-protocol population includes 69 participants who received at least one dose of their assigned study medication.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYVeterans Aging Cohort Study (VACS) IndexBaseline and 24 weeksscore on a scaleMEAN
SECONDARYCD4 CountBaseline and 24 weekscells/mm3MEAN
SECONDARYEngagement in HIV Care: Antiretroviral Therapy PrescribedBaseline and 24 weeksNumber analyzed at 24 weeks lower than baseline due to study retention and availability of data.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEngagement in HIV Care: 100% Antiretroviral Therapy Adherence24 weeks
This outcome measure is based on participant self-report. As such, fewer participants provided data for this outcome measure than other measures where data was obtained through pharmacy or clinic attendance logs.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With at Least 1 HIV Care Visit in Past 12 Weeks24 weeks
This outcome measure is based on participant self-report. As such, fewer participants provided data for this outcome measure than other measures where data was obtained through pharmacy or clinic attendance logs.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants Who Had Unprotected Sex in Past 30 DaysBaseline and 24 weeksThose reporting no sex are excluded.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Multiple Sex Partners in Past 30 DaysBaseline and 24 weeksTwo or more sex partners during past month, those reporting no sex partners are excludedParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEngagement in HIV Care: Quality of LifeBaseline and 24 weeksscore on a scaleMEAN
SECONDARYAverage Number of Self-Reported Days of Opioid Use in Last 30 DaysBetween baseline and 24 weeksPer-protocol population includes participants who received at least one dose of their assigned study medication.daysMEAN
SECONDARYNumber of Participants Who Test Positive for Opioids at 24 Weeks24 weeksPer-protocol population includes participants who received at least one dose of their assigned study medication.ParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03275350/outcomes